FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu™ Lens System in Patients with Cataracts
The OmniVu is arevolutionary dual-optic lens designed to restore dynamic visual function by harnessing the eye’s natural accommodative mechanism while preserving its anatomical integrity. Global clinical trials show promising long-term predictability and stability in more than 75 treated eyes. CAMPBELL, Calif.–(BUSINESS WIRE)–Atia Vision, Inc., a Shifamed portfolio company, today announced it has received Investigational Device […]